Ordinær generalforsamling i ALK-Abelló A/S den 14. marts 2024
February 16, 2024 08:00 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): Ordinær generalforsamling i ALK-Abelló A/S finder sted torsdag den 14. marts 2024 kl. 16.00 hos ALK-Abelló A/S, Bøge Allé 1, 2970 Hørsholm i henhold til vedhæftede...
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
February 12, 2024 10:15 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): I henhold til artikel 19 i EU forordning nr. 596/2014 af 16. april 2014 om markedsmisbrug (markedsmisbrugsforordningen), følger hermed indberetning af ledende...
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
February 12, 2024 10:15 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the...
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
February 12, 2024 05:30 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): I henhold til artikel 19 i EU forordning nr. 596/2014 af 16. april 2014 om markedsmisbrug (markedsmisbrugsforordningen), følger hermed indberetning af ledende...
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
February 12, 2024 05:30 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the...
Annual report 2023: ALK delivers 9% sales growth with profits up 50%
February 08, 2024 07:35 ET
|
ALK Abello
08 February 2024 ALK’s (ALKB:DC / OMX: ALK B / AKBLF) Board of Directors has approved the company’s 2023 annual report. Following a robust performance in Q4, full-year results were in line with the...
ALK and McMaster researchers discover new cell that remembers allergies
February 07, 2024 14:10 ET
|
ALK Abello
Researchers with McMaster University and Denmark-based pharmaceutical company ALK-Abelló A/S have made a ground-breaking discovery: a new cell that remembers allergies. The discovery gives...
ALK’s 2030 CO2 reduction targets have been approved by SBTi
February 05, 2024 03:30 ET
|
ALK Abello
ALK’s near-term carbon reduction targets for scope 1, 2 and 3 have been validated and approved by the Science Based Targets initiative. Today, ALK announces that its near-term carbon reduction...
Dato for offentliggørelse af årsrapport for 2023 for ALK og webcast
January 31, 2024 03:44 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF) offentliggør årsrapport for 2023 torsdag den 8. februar 2024 om eftermiddagen. ALK afholder samme dag kl. 16.00 (CET) en telekonference for investorer og...
Release date of annual report 2023 for ALK and webcast
January 31, 2024 03:44 ET
|
ALK Abello
On Thursday, 8 February 2024 in the afternoon, ALK (ALKB:DC / OMX: ALK B / AKBLF) releases its annual report for 2023. ALK will host an online meeting for analysts and institutional investors...